PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Vismodegib in basal cell carcinoma: Added benefit not proven

Hardly any patient-relevant outcomes were investigated/ studies without control groups

2013-11-18
(Press-News.org) Contact information: Dr. Anna-Sabine Ernst
presse@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Vismodegib in basal cell carcinoma: Added benefit not proven Hardly any patient-relevant outcomes were investigated/ studies without control groups The drug vismodegib (trade name: Erivedge) is approved for the treatment of patients with two forms of basal cell carcinoma (BCC): symptomatic metastatic BCC and locally advanced BCC inappropriate for surgery or radiotherapy.

In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy. However, no added benefit can be derived from the data presented in the company's dossier.

Currently hardly any chances of cure in advanced basal cell carcinoma

Basal cell carcinoma (also called "basalioma") is a malignant form of skin cancer, which mainly occurs on the head or neck. In most cases, timely surgery can prevent it from spreading. In an aggressive ("locally advanced") form and the occurrence of metastases, however, treatment options are limited. Often only symptoms can be relieved, but cure is no longer possible.

The manufacturer has now presented data from an approval study. According to this study, tumours shrank under vismodegib in some patients with symptomatic metastatic or locally advanced BCC.

G-BA distinguished different comparator therapies

The Federal Joint Committee (G-BA) specified several appropriate comparator therapies: In patients with symptomatic metastatic BCC for whom surgery was not an option, the drug was to be compared with radiotherapy. In patients with symptomatic metastatic BCC for whom radiotherapy was inappropriate, surgery was to be used as comparator therapy. In patients with symptomatic metastatic or locally advanced BCC for whom neither radiotherapy nor surgery was an option, the benefit of vismodegib was to be compared with the benefit of best supportive care. "Best supportive care" means palliative treatment tailored to the individual patient, i.e. a treatment that does not aim to cure, but to alleviate symptoms as good as possible (e.g. with adequate pain therapy) and improve quality of life.

Pharmaceutical company deviated from the G-BA's specification

In contrast to the G-BA's specifications, the pharmaceutical company exclusively compared its drug with best supportive care – claiming that surgery and radiotherapy in symptomatic metastatic BCC also had only a palliative effect. IQWiG did not accept this deviation from the specified appropriate comparator therapy: If it is assumed that different treatments are optimal for different patient groups, this differentiation also has to have an effect on the control groups.

Studies unsuitable for assessing the added benefit

However, the main problem was that the dossier was based solely on studies without control groups. An added benefit can only be derived from this kind of studies if "dramatic" patient-relevant effects occur in these studies. To estimate the effect size, other studies would have to be used for comparison – in this case, studies known as "historical controls". If, for example, most patients died early in the historical controls, but many patients survived longer in the study with the new drug, this would be a "dramatic effect".

Based on the study data submitted, it was not possible to assess whether there were dramatic effects with regards to patient-relevant outcomes because tumour regression mainly measured with imaging techniques (the so-called "objective response rate") is a surrogate outcome and not necessarily patient-relevant. Moreover, the pharmaceutical company did not present any data on the appropriate comparator therapy so that no comparison could be made. Hence an added benefit versus the appropriate comparator therapy is not proven.

G-BA decides on the extent of added benefit

The dossier assessment is part of the overall procedure for early benefit assessments supervised by the G-BA. After publication of the manufacturer's dossier and IQWiG's assessment, the G-BA conducts a commenting procedure, which may provide further information and result in a change to the benefit assessment. The G-BA then decides on the extent of the added benefit, thus completing the early benefit assessment.

An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the website gesundheitsinformation.de, published by IQWiG, provides easily understandable and brief German-language information on vismodegib.

### The G-BA website contains both general English-language information on benefit assessment pursuant to §35a Social Code Book (SGB) V and specific German-language information on the assessment of vismodegib.

More English-language information will be available soon (Sections 2.1 to 2.6 of the dossier assessment as well as subsequently published health information on informedhealthonline.org). If you would like to be informed when these documents are available, please send an e-mail to info@iqwig.de.


ELSE PRESS RELEASES FROM THIS DATE:

Amber provides new insights into the evolution of the Earth's atmosphere

2013-11-18
Amber provides new insights into the evolution of the Earth's atmosphere Scientists encounter big challenges when reconstructing atmospheric compositions in the Earth's geological past because of the lack of useable sample material. One of the few ...

Would an 'anti-ketamine' also treat depression?

2013-11-18
Would an 'anti-ketamine' also treat depression? Yes, says a new study in Biological Psychiatry Philadelphia, PA, November 18, 2013 – Thirteen years ago, an article in this journal first reported that the anesthetic medication, ketamine, showed evidence of producing ...

More than 600 ancient seals and amulets found

2013-11-18
More than 600 ancient seals and amulets found Archaeologists from the Cluster of Excellence make an unusually large find in Turkey -- surprisingly vivid insights into the piety of the time Classical scholars from the Cluster of Excellence "Religion ...

Nature: Single-atom bit forms smallest memory in the world

2013-11-18
Nature: Single-atom bit forms smallest memory in the world This news release is available in German. One atom equals one bit: According to this design principle, we would like to construct magnetic data memories in the future. Presently, a compound of several ...

First EU e-Inclusion map measures the potential for improved digital literacy

2013-11-18
First EU e-Inclusion map measures the potential for improved digital literacy An EU-27 survey of intermediary organisations operating on the education, social and employment sectors and providing IT training has produced a first ever assessment ...

Cesarean delivery doesn't lower risk of cerebral palsy

2013-11-18
Cesarean delivery doesn't lower risk of cerebral palsy Cesarean deliveries do not prevent children from developing cerebral palsy, despite long-held medical and community beliefs about the causes of cerebral palsy, according to new research ...

A study led by CNIO validates a new anti-cancer therapy based on cell division

2013-11-18
A study led by CNIO validates a new anti-cancer therapy based on cell division The study confirms the therapeutic potential of inhibiting Aurora-A in cancer treatment Aurora-A is a protein involved in the cell division process that is highly expressed ...

Spanish scientists are designing a robot for inspecting tunnels

2013-11-18
Spanish scientists are designing a robot for inspecting tunnels Currently, maintenance and safety inspection of tunnels used for vehicular traffic is carried out by direct in situ observation. This process, which is slow and requires intensive labor, requires that traffic ...

Boredom research has now become more interesting

2013-11-18
Boredom research has now become more interesting Researchers identify fifth type of tedium -- apathetic boredom Being bored has just become a little more nuanced, with the addition of a fifth type of boredom by which to describe this emotion. The finding has been published ...

Teens who drink alone more likely to develop alcohol problems as young adults

2013-11-18
Teens who drink alone more likely to develop alcohol problems as young adults Results also show adolescents drink alone to cope with negative emotions PITTSBURGH—Most teenagers who drink alcohol do so with their friends in social settings, but a new study by researchers ...

LAST 30 PRESS RELEASES:

ACP’s Best Practice Advice addresses use of cannabis, cannabinoids for chronic noncancer pain

Beyond photorespiration: A systematic approach to unlocking enhanced plant productivity

How a small number of mutations can fuel outbreaks of western equine encephalitis virus

Exposure to wildfire smoke linked with worsening mental health conditions

Research uncovers hidden spread of one of the most common hospital-associated infections

Many older adults send their doctors portal messages, but who pays?

Fine particulate matter from 2020 California wildfires and mental health–related emergency department visits

Gender inequity in institutional leadership roles in US academic medical centers

Pancreatic cells ‘remember’ epigenetic precancerous marks without genetic sequence mutations

Rare combination of ovarian tumors found in one patient

AI-driven clinical recommendations may aid physician decision making to improve quality of care

Artificial intelligence has potential to aid physician decisions during virtual urgent care

ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025

New study reveals polymers with flawed fillers boost heat transfer in plastics

Signs identified that precede sudden arrhythmic death syndrome in young people

Discovery of bacteria's defence against viruses becomes a piece of the puzzle against resistance

Pre-eclampsia is associated with earlier onset and higher incidence of cardiovascular risk factors

Warwick astronomers discover doomed pair of spiralling stars on our cosmic doorstep

Soil conditions significantly increase rainfall in world’s megastorm hotspots

NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma

Planetary health diet and mediterranean diet associated with similar survival and sustainability benefits

Singapore launches national standard to validate antimicrobial disinfectant products

Molecular stool test could improve detection of tuberculosis in adults with HIV

Suspected fibrocartilaginous embolus in Asian small-clawed otter (Aonyx cinereus)

Enhancing heat transfer using the turbulent flow of viscoelastic fluids

Exercise as an anti-ageing intervention to avoid detrimental impact of mental fatigue

UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’

New guidelines aim to improve cystic fibrosis screening

Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

[Press-News.org] Vismodegib in basal cell carcinoma: Added benefit not proven
Hardly any patient-relevant outcomes were investigated/ studies without control groups